ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Italians join for new drugs

July 31, 2006 | APPEARED IN VOLUME 84, ISSUE 31

Indena has commissioned Nerviano Medical Sciences, the largest pharmaceutical R&D facility in Italy, to scale up and produce two drug candidates for preclinical and clinical development. Indena, which specializes in plant extracts, derived the molecules from plants and worked out a semisynthetic path for them. One molecule, the thiocolchicine dimer IDN 5404, acts on tumors resistant to cisplatin and topotecan. The second, IDN 5243, is a relaxant for the treatment of muscular skeletal pain.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment